Understanding osteoporosis

Journal of Psychopharmacology

Volumn 22, Issue 2 SUPPL., 2008, Pages 38-45

  Javaid, M Kassim ^a   Holt, Richard I G ^a,b  

^a UNIVERSITY OF SOUTHAMPTON   (United Kingdom)

^b SOUTHAMPTON GENERAL HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

NEUROLEPTIC AGENT;

CHEMICALLY INDUCED DISORDER; FRACTURE; HUMAN; HYPERPROLACTINEMIA; MENTAL DISEASE; OSTEOPOROSIS; REVIEW; RISK ASSESSMENT; RISK FACTOR;

ANTIPSYCHOTIC AGENTS; FRACTURES, BONE; HUMANS; HYPERPROLACTINEMIA; MENTAL DISORDERS; OSTEOPOROSIS; RISK ASSESSMENT; RISK FACTORS;

EID: 51149117097     PISSN: 02698811     EISSN: 14617285     Source Type: Journal    
DOI: 10.1177/0269881107087955     Document Type: Article

References (49)

1. Abraham G, Halbreich U, Friedman RH, Josiassen RC (2003) Bone mineral density and prolactin associations in patients with chronic schizophrenia. Schizophr Res 59: 17-18
2. Almeras L, Eyles D, Benech P, Laffite D, Villard C, Patatian A, Boucraut J, Mackay-Sim A, McGrath J, Feron F (2007) Developmental vitamin D deficiency alters brain protein expression in the adult rat: implications for neuropsychiatric disorders. Proteomics 7: 769-780
3. Becker D, Liver O, Mester R, Rapoport M, Weizman A, Weiss M (2003) Risperidone, but not olanzapine, decreases bone mineral density in female premenopausal schizophrenia patients. J Clin Psychiatry 64: 761-766
4. Biller BM, Coughlin JF, Saxe V, Schoenfeld D, Spratt DI, Klibanski A (1991) Osteopenia in women with hypothalamic amenorrhea: a prospective study. Obstet Gynecol 78: 996-1001
5. Bonjour JP, Carrie AL, Ferrari S, Clavien H, Slosman D, Theintz G, Rizzoli R (1997) Calcium-enriched foods and bone mass growth in prepubertal girls: a randomized, double-blind, placebo-controlled trial. J Clin Invest 99: 1287-1294
6. Bowman BM, Siska CC, Miller SC (2002) Greatly increased cancellous bone formation with rapid improvements in bone structure in the rat maternal skeleton after lactation. J Bone Miner Res 17: 1954-1960
7. Cann CE, Martin MC, Genant HK, Jaffe RB (1984) Decreased spinal mineral content in amenorrheic women. JAMA 251: 626-629
8. Casanueva FF, Molitch ME, Schlechte JA, Abs R, Bonert V, Bronstein MD, Brue T, Cappabianca P, Colao A, Fahlbusch R, Fideleff H, Hadani M, Kelly P, Kleinberg D, Laws E, Marek J, Scanlon M, Sobrinho LG, Wass JA, Giustina A (2006) Guidelines of the Pituitary Society for the diagnosis and management of prolactinomas. Clin Endocrinol 65: 265-273
9. Chevalley T, Rizzoli R, Hans D, Ferrari S, Bonjour JP (2005) Interaction between calcium in-ake and menarcheal age on bone mass gain: an 8-year follow-up study from pre-puberty to postmenarche. J Clin Endocrinol Metab 90: 44-51
10. Clement-Lacroix P, Ormandy C, Lepescheux L, Ammann P, Damotte D, Goffin V, Bouchard B, Amling M, Gaillard-Kelly M, Binart N, Baron R, Kelly PA (1999) Osteoblasts are a new target for prolactin: analysis of bone formation in prolactin receptor knockout mice. Endocrinol 140: 96-105
11. Colao A, Di Somma C, Loche S, Di Sarno A, Klain M, Pivonello R, Pietrosante M, Salvatore M, Lombardi G (2000) Prolactinomas in adolescents: persistent bone loss after 2 years of prolactin normalization. Clin Endocrinol 52: 319-327
12. Cooper C, Westlake S, Harvey N, Javaid K, Dennison E, Hanson M (2006) Review: developmental origins of osteoporotic fracture. Osteoporos Int 17: 337-347
13. Coss D, Yang L, Kuo CB, Xu X, Luben RA, Walker AM (2000) Effects of prolactin on osteoblast alkaline phosphatase and bone formation in the developing rat. Am J Physiol Endocrinol Metab 279: E1216-E1225
14. Delva NJ, Crammer JL, Jarzylo SV, Lawson JS, Owen JA, Sribney M, Weir BJ, Yendt ER (1989) Osteopenia, pathological fractures, and increased urinary calcium excretion in schizophrenic patients with polydipsia. Biol Psychiatry 26: 781-793
15. Dennison E, Mohamed MA, Cooper C (2006) Epidemiology of osteoporosis. Rheum Dis Clin North Am 32: 617-629
16. Duan Y, Beck TJ, Wang XF, Seeman E (2003) Structural and biomechanical basis of sexual dimorphism in femoral neck fragility has its origins in growth and aging. J Bone Miner Res 18: 1766-1774
17. Frost HM, Schonau E (2001) On longitudinal bone growth, short stature, and related matters: insights about cartilage physiology from the Utah paradigm. J Pediatr Endocrinol Metab 14: 481-496
18. Ferrari S, Rizzoli R, Bonjour JP (1998) Heritable and nutritional influences on bone mineral mass. Aging (Milano) 10: 205-213
19. Grafe IA, Da Fonseca K, Hillmeier J, Meeder PJ, Libicher M, Nöldge G, Bardenheuer H, Pyerin W, Basler L, Weiss C, Taylor RS, Nawroth P, Kasperk C (2005) Reduction of pain and fracture incidence after kyphoplasty: 1-year outcomes of a prospective controlled trial of patients with primary osteoporosis. Osteoporos Int 16: 2005-2012
20. Grant AM, Avenell A, Campbell MK, McDonald AM, MacLennan GS, McPherson GC, Anderson FH, Cooper C, Francis RM, Donaldson C, Gillespie WJ, Robinson CM, Torgerson DJ, Wallace WA. ; RECORD Trial Group (2005) Oral vitamin D3 and calcium for secondary prevention of low-trauma fractures in elderly people (Randomised Evaluation of Calcium Or vitamin D, RECORD): a randomised placebo-controlled trial. Lancet 365: 1621-1628
21. Greenspan SL, Oppenheim DS, Klibanski A (1989) Importance of gonadal steroids to bone mass in men with hyperprolactinemic hypogonadism. Ann Intern Med 110: 526-531
22. Hernandez CJ, Beaupre GS, Carter DR (2003) A theoretical analysis of the relative influences of peak BMD, age-related bone loss and menopause on the development of osteoporosis. Osteoporos Int 14: 843-847
23. Howard L, Kirkwood G, Leese M (2007) Risk of hip fracture in patients with a history of schizophrenia. Br J Psychiatry 190: 129-134
24. Howes O (2004) Bone mineral density and prolactin associations in patients with chronic schizophrenia. Schizophr Res 66: 77-78
25. Howes OD, Wheeler MJ, Pilowsky LS, Landau S, Murray RM, Smith S (2007) Sexual function and gonadal hormones in patients taking antipsychotic treatment for schizophrenia or schizoaffective disorder. J Clin Psychiatry 68: 361-367
26. Hui SL, Slemenda CW, Johnston CC (1988) Age and bone mass as predictors of fracture in a prospective study. J Clin Invest 81: 1804-1809
27. Hummer M, Malik P, Gasser RW, Hofer A, Kemmler G, Moncayo Naveda RC, Rettenbacher MA, Fleischhacker WW (2005) Osteoporosis in patients with schizophrenia. Am J Psychiatry 162: 162-167
28. Javaid MK, Cooper C (2002) Prenatal and childhood influences on osteoporosis. Best Pract Res Clin Endocrinol Metab 16: 349-367
29. Johnell O, Kanis JA (2006) An estimate of the worldwide prevalence and disability associated with osteoporotic fractures. Osteoporos Int 17: 1726-1733
30. Jung DU, Conley RR, Kelly DL, Kim DW, Yoon SH, Jang JH, Shin JG, Shim JC (2006) Prevalence of bone mineral density loss in Korean patients with schizophrenia: a cross-sectional study. J Clin Psychiatry 67: 1391-1396
31. Katalinic A, Rawal R (2008) Decline in breast cancer incidence after decrease in utilisation of hormone replacement therapy. Breast Cancer Res Treat Apr 107: 427-430
32. Keen RW (2003) Burden of osteoporosis and fractures. Curr Osteoporos Rep 1: 66-70
33. Klibanski A, Greenspan SL (1986) Increase in bone mass after treatment of hyperprolactinemic amenorrhea. N Engl J Med 315: 542-546
34. Klibanski A, Neer RM, Beitins IZ, Ridgway EC, Zervas NT, McArthur JW (1980) Decreased bone density in hyperprolactinemic women. N Engl J Med 303: 1511-1514
35. Koppelman MC, Kurtz DW, Morrish KA, Bou E, Susser JK, Shapiro JR, Loriaux DL (1984) Vertebral body bone mineral content in hyperprolactinemic women. J Clin Endocrinol Metab 59: 1050-1053
36. Lehman D, Meyer JM (2005) Decreased bone mineral density in male schizophrenia patients. Schizophr Res 76: 131-133
37. Martin TJ, Gillespie MT (2001) Receptor activator of nuclear factor kappa B ligand (RANKL): another link between breast and bone. Trends Endocrinol Metab 12: 2-4
38. Miller SC, Bowman BM (2007) Rapid inactivation and apoptosis of osteoclasts in the maternal skeleton during the bone remodeling reversal at the end of lactation. Anat Rec A Discov Mol Cell Evol Biol. 290: 65-73
39. Naidoo U, Goff DC, Klibanski A (2003) Hyperprolactinemia and bone mineral density: the potential impact of antipsychotic agents. Psychoneuroendocrinology 28(Suppl 2): 97-108
40. O'Keane V, Meaney AM (2005) Antipsychotic drugs: a new risk factor for osteoporosis in young women with schizophrenia? J Clin Psychopharmacol 25: 26-31
41. Puntheeranurak S, Charoenphandhu N, Krishnamra N (2006) Enhanced trabecular-bone calcium deposition in female rats with a high physiological dose of prolactin diminishes after ovariectomy. Can J Physiol Pharmacol 84: 993-1002
42. Redelmeier DA, Tan SH, Booth GL (1998). The treatment of unrelated disorders in patients with chronic medical diseases. N Engl J Med 338: 1516-1520
43. Riggs BL, Parfitt AM (2005) Drugs used to treat osteoporosis: the critical need for a uniform nomenclature based on their action on bone remodeling. J Bone Miner Res 20: 177-184
44. Rosano M, Vitale C, Fini M (2006) Hormone replacement therapy and cardioprotection: what is good and what is bad for the cardiovascular system? Ann NY Acad Sci 1092: 341-348
45. Seeman E, Hopper JL, Bach LA, Cooper ME, Parkinson E, McKay J, Jerums G (1989). Reduced bone mass in daughters of women with osteoporosis. N Engl J Med 320: 554-558
46. Specker B, Binkley T (2003) Randomized trial of physical activity and calcium supplementation on bone mineral content in 3-to 5-year-old children. J Bone Miner Res 18: 885-892
47. Vestergaard P, Rejnmark L, Mosekilde L (2006) Anxiolytics, sedatives, antidepressants, neuroleptics and the risk of fracture. Osteoporos Int 17: 807-816
48. World Health Organisation (1994) Assessment of fracture risk and its application to screening for postmenopausal osteoporosis. World Health Organ Tech Rep Ser 843: 1-129
49. Yarden PE, Finkel MG, Raps CS, Girvan JJ (1989) Adverse outcome of hip fractures in older schizophrenic patients. Am J Psychiatry 146: 377-379